Share Name Share Symbol Market Type Share ISIN Share Description
Filtrona Plc LSE:FLTR London Ordinary Share GB00B0744359 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 683.00p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 663.4 76.9 25.0 27.3 1,602.13

Filtrona (FLTR) Latest News

Filtrona News

Date Time Source Headline
12/11/201518:10UKREGEssentra plc Director/PDMR Shareholding
10/11/201514:20UKREGEssentra plc Director/PDMR Shareholding
09/11/201512:03UKREGEssentra plc Director/PDMR Shareholding
02/11/201510:49UKREGEssentra plc Total Voting Rights
29/10/201512:13UKREGEssentra plc Director/PDMR Shareholding
More Filtrona News
Filtrona Takeover Rumours

Filtrona (FLTR) Share Charts

1 Year Filtrona Chart

1 Year Filtrona Chart

1 Month Filtrona Chart

1 Month Filtrona Chart

Intraday Filtrona Chart

Intraday Filtrona Chart

Filtrona (FLTR) Discussions and Chat

Filtrona Forums and Chat

Date Time Title Posts
04/8/201314:38Filtrona - Flying in FTSE250101

Add a New Thread

Filtrona (FLTR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Filtrona trades in real-time

Filtrona (FLTR) Top Chat Posts

Filtrona Daily Update: Filtrona Plc is listed in the Support Services sector of the London Stock Exchange with ticker FLTR. The last closing price for Filtrona was 683p.
Filtrona Plc has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 234,571,864 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Filtrona Plc is £1,602,125,831.12.
werty5: IMS did not move the share price could be because stock has held up quite well in the recent market down turn. Could be 101 things who knows? still a cracking share imho.
bluebelle: Colin Day, chief executive of Filtrona, reluctantly accepts that his £1.3 billion company is a type of conglomerate. When such beasts as Hanson Trust and Williams Holdings last stalked the corporate jungle, they were indeed collections of seemingly unconnected businesses; Filtrona contains within it a maker of cigarette filters and one providing labels on drugs and healthcare products, and again, it is hard to see much connection between these. However, making cigarette filters is a strongly defensive business, as is making cigarettes themselves, and provides excellent cashflow, from a market growing at 11 to 12 per cent a year, as Filtrona wins market share and smokers in emerging territories switch to more sophisticated brands. The market supplying pharmaceutical products is likewise growing by 8 or 9 per cent a year, driven by the usual demographics: an ageing population and more sophisticated healthcare in those emerging markets. Regulation is increasing the amount of information consumers must be given. Mr Day says Filtrona, spun out of Bunzl when the latter decided to devote itself purely to distribution, is in essence a maker of foam, fibre, filter and plastic products that are high volume, relatively low value, and essential. He has placed a further bet on those pharmaceuticals markets with the £160 million purchase from private equity of Contego Healthcare, a UK company that provides print and packaging. This is the biggest deal so far for a business more inclined to small bolt-ons and is funded by means of a placing of new shares equivalent to almost 10 per cent of the issued share capital. Filtrona had tended to fund smaller deals out of debt but had always made it clear that anything significant would be funded by fresh equity. The market had no qualms; the placing went through without a hitch at 675p, a premium to the price in the market at the time, and Filtrona shares ended 28p ahead at 690½p. The business being acquired has lower margins than the division it is joining, there are plenty of cost savings available, and Contego products can be sold to Filtrona's existing customers and vice-versa. It looks like a textbook deal. Filtrona has ambitious plans but is already just short of a share price target set only two years ago. The shares sell on almost 19 times this year's earnings, which looks high, but farther progress looks assured in due course. Buy on any weakness.
werty5: Fundamentals look good for Filtrona. Also looking at the weekly chart MACD Histogram looks like it is just entering a new trend ticking upward and EMA based on a 26 week (half year) also trending higher, so share price looks set to rise for a little while yet, with luck.
quickmind: ... A third quarter trading update that was merely in line with expectations was a cue for a round of profit taking in Filtrona, the international supplier of speciality plastic and fibre products. Panmure Gordon thinks that with the shares closing last night at a 52-week high of 259p the stock is no longer worth buying, though that view was expressed before the market knocked more than 5% off the share price in the morning session. Panmure Gordon switches its stance from "buy" to "hold" but maintains its 274p price target after the company achieved slightly better overall growth in the third quarter than the broker was expecting. The broker notes, however, that "there are a number of issues within the mix." These include a cautionary note on growth in the porous technologies division in the fourth quarter as a result of overstocking by its largest customers, and cigarette tax changes in Japan bringing filter orders forwards into the third quarter. The broker's full year expectations remain unchanged though it has fiddled around with the forecast margins of the group's various divisions. "We believe Filtrona continues to make significant progress, though as is always the case it may pay not to get too carried away too far in advance," the broker said.
cockneyrebel: It was undoubtedly a good day for investors in Filtrona yesterday as the group surprised the City by saying it was doing better than expected. The dividend yield alone justifies a buy recommendation and yesterday's share price jump shows that Filtrona is now on the market's radar. The case for buying shares in Filtrona is compelling and investors should fill their boots. Buy, says the Independent.
conan the trader: I saw a decent write-up on Filtrona in the Telegraph a few days ago, so was is the share price falling for the 6th successive month?
Filtrona share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20161024 08:50:50